Evotec SE Share Price Other OTC
Equities
EVTCY
US30050E1055
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.585 USD | -93.79% | 0.00% | 0.00% |
06:25pm | German Stocks Reverse Two-Session Losing Streak | DJ |
06-25 | Sector Update: Health Care Stocks Advance Pre-Bell Tuesday | MT |
Sales 2024 * | 883M 945M 74.72B | Sales 2025 * | 1.04B 1.11B 87.85B | Capitalization | 1.5B 1.61B 127B |
---|---|---|---|---|---|
Net income 2024 * | -28M -29.98M -2.37B | Net income 2025 * | 31M 33.19M 2.62B | EV / Sales 2024 * | 1.96 x |
Net Debt 2024 * | 227M 243M 19.22B | Net Debt 2025 * | 186M 200M 15.79B | EV / Sales 2025 * | 1.63 x |
P/E ratio 2024 * |
-56.2
x | P/E ratio 2025 * |
33.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 18/06/19 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 06/02/23 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 30/04/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 18/06/19 |
Roland Sackers
BRD | Director/Board Member | 56 | 18/06/19 |
Chairman | 63 | 16/06/14 |
1st Jan change | Capi. | |
---|---|---|
+21.21% | 46.93B | |
+37.63% | 39.08B | |
-8.15% | 38.48B | |
+29.34% | 31.01B | |
-13.75% | 26.14B | |
+11.05% | 25.88B | |
+36.22% | 12.53B | |
-6.91% | 11.36B | |
-12.82% | 10.65B |
- Stock Market
- Equities
- EVT Stock
- EVTCY Stock